Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454297 · ClinicalTrials.gov registry record
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
A clinical trial, sponsored by Multiple Myeloma Research Foundation.
- Completed
- Registry status
- 1,154
- Enrollment target
NCT01454297 is a clinical trial that has completed, run by Multiple Myeloma Research Foundation. The registered enrollment target is 1,154 participants.
The verdict
NCT01454297 has completed, sponsored by Multiple Myeloma Research Foundation.
- COMPLETED
- Registry status
- 1,154 participants
- Enrollment target
Study Summary
The primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients during the course of the disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,154 participants |
| Start Date | 2011-07 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01454297
The ClinicalTrials.gov registry entry for NCT01454297 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Multiple Myeloma Research Foundation, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01454297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01454297 about?
NCT01454297 is a clinical study titled "Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile". The primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients during the course of the disease.
What is the current status of trial NCT01454297?
This trial is currently completed. The enrollment target is 1,154 participants. The study started on 2011-07. Estimated completion is 2023-12-31.
Who is sponsoring clinical trial NCT01454297?
This trial is sponsored by Multiple Myeloma Research Foundation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.